RELIAGRIP Trademark

Trademark Overview


On Thursday, February 15, 2024, a trademark application was filed for RELIAGRIP with the United States Patent and Trademark Office. The USPTO has given the RELIAGRIP trademark a serial number of 98407476. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, October 28, 2024. The RELIAGRIP trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in surgery; Surgical and medical apparatus and instruments for use in general surgery
reliagrip

General Information


Serial Number98407476
Word MarkRELIAGRIP
Filing DateThursday, February 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkRELIABLE GRIP
Goods and ServicesMedical apparatus and instruments for use in surgery; Surgical and medical apparatus and instruments for use in general surgery

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 15, 2024
Primary Code010
First Use Anywhere DateSaturday, January 15, 2022
First Use In Commerce DateSaturday, January 15, 2022

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressGreensboro, NC 27408

Trademark Events


Event DateEvent Description
Thursday, February 15, 2024NEW APPLICATION ENTERED
Tuesday, June 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 28, 2024NON-FINAL ACTION E-MAILED
Monday, October 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 28, 2024NON-FINAL ACTION WRITTEN
Sunday, September 8, 2024ASSIGNED TO EXAMINER